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CASE REPORT
Fungal osteomyelitis in a patient with chronic granulomatous disease: Case
report and review of the literature
Muhammad Khalid, Syed Asad Ali

Abstract
Chronic granulomatous disease (CGD) is the most
common of the primary immunodeficiency in children. It
is caused by single gene defect resulting in dysfunctional
nicotinamide adenine dineucleotide phosphate (NADPH)
oxidase complex causing recurrent bacterial and fungal
infections. Here we present the case of a 9 year old boy
who was a known case of CGD since three years of age. He
presented with recent history of fever, left sided pain in
the scapular region and difficulty in breathing. Chest
imaging revealed developing left upper lobe
consolidation and erosion of the 3rd posterior rib. The
child underwent video assisted thoracoscopic surgery
(VATS) and biopsy of the lesion. Histopathology revealed
fungal hyphae which were confirmed to be Aspergillus
nidulans on staining. He was successfully treated with
voriconazole therapy. We will also review the literature on
fungal osteomyelitis in CGD patients.
Keywords: chronic granulomatous disease, primary
immunodeficiency, Aspergillus nidulans, osteomyelitis.

Introduction
Chronic granulomatous disease (CGD) is a rare genetic
condition where nicotinamide adenine dineucleotide
phosphate (NADPH) oxidase complex fails to generate
reactive oxygen species (ROS) in the activated
neutrophils, monocytes and macrophages.1 CGD is a
single gene defect; either X-linked recessive (XR - CGD) in
60% of the cases or autosomal recessive (AR - CGD) in 40%
of the cases. Approximate incidence of CGD is 1 in
200,000 persons.2
Two thirds (75%) of the patients under five years of age
present with recurrent infections. X-linked recessive CGD
is more severe and early to present.3 The infections most
commonly involve lungs, lymph nodes, skin, liver and
gastrointestinal tract. Common pathogenic organism
include Aspergillus (fumigates, nidulans), Staphylococcus
aureus, Burkholderiacepacia, Salmonella species, Serratia
marcescens, Mycobacterium tuberculosis and Nocardia.4
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The first clue to investigate for this disorder comes from
carefully obtained medical or family history of repeated
and/or extraordinarily severe infections. Measurement of
superoxide production by the activated phagocytes is the
basis
of
diagnostic
tests.
These
include
nitrobluetetrazoleum
(NBT)
reduction
and
dihydrorhodamine (DHR) assay. Other adjunct diagnostic
modalities are imaging techniques (CT, MRI and MR spectroscopy), histopathology and culture sensitivity of
biopsy specimens.5
Close medical follow-up, prophylactic antibiotic and
antifungal therapy with aggressive treatment of acute
infections form the basis of standard care for the patients
with CGD. Trimethoprim-sulphamethoxazole and
itraconazole are the agents of choice for prophylaxis. In
some of the developed countries like USA interferon —
gamma therapy is also used for prophylaxis. Definitive
therapy for CGD is the stem cell transplantation.6
Here we present a case of Aspergillus nidulans pneumonia
with posterior rib erosion in a nine year old boy who was
a known case of CGD seen at Aga Khan University
Hospital in July 2017. Histopathology and culture
sensitivity of the biopsy specimen confirmed the
diagnosis and the boy had uneventful recovery.
Literature review of Aspergillus osteomyelitis in CGD
patients is also presented.

Case Report
A nine year old boy presented in outpatient department
with fever, left sided pain in scapular region and difficulty
in breathing for three days. There was no history of
trauma associated with pain. The boy was a diagnosed
case of chronic granulomatous disease, based on
nitrobluetetrazoleum test (NBT) and dihydrorhodamine
(DHR) assay, since three years of age and his regular
medication included Trimethoprim-sulphamethoxazole 5
mg/kg/day in two divided daily doses and Itraconazole 5
mg/kg oral solution once daily.
Clinical examination revealed a febrile boy with a
temperature of 102°F. Respiratory system examination
was significant with pain on deep inspiration, dull
percussion note and decreased air entry in left upper
J Pak Med Assoc
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Table: Aspergillus osteomyelitis in CGD patients.
S. No

Reference

Age (year)/
Gender

Genotype

Year of
publication

Aspergillus
species

Site

1

Dellepiane et al9

21 /M

gp91phox

2008

A. nidulans

2
3

Bukhari et al14
Hodiamont et al10

5/M
18 / M

NA
gp91phox

2009
2009

A. nidulans
A. fumigatus

5th, 6th, 7th thoracic
vertebrae + ribs
Vertebrae
Right midfoot

4

Al-Tawfiq et al15

17 / M

NA

2010

A. fumigatus

6th & 7th cervical + 1st , 2nd,
3rd& 4th thoracic vertebrae

9/M

gp91phox

2010

A. fumigatus

Skull osteomyelitis
(left supra - orbital)
L3-L4 spondylo-discitis +
paraspinal / epidural abscess
Right tibia

5 Mohammadpour M et al8

6

Chang H-M et al11

17 / M

p47-phox

2012

A. flavus

7

Bassiri-Jahromi S et al12

13 / M

X-linked

2012

A. nidulans

8

Kepenekli E et al13

2.5 / M

X-linked

2014

Aspergillus spp.

9

Mamishi S et al16

4.5 / F

NA

2016

A. fumigatus

10

Kutlug S et al7

11 / M

gp91phox

2017

A. fumigatus

Right 2 costal bones
& cartilages with
lung parenchyma
9th& 10th posterior right
ribs+ Lung abscess g
progressed to involve right 3rd rib,
left 5th , 6th , 7th and 8th ribs
Talus & vertebral osteomyelitis

Therapy
LAMB* + caspofungin g
caspofungin & voriconazole
Voriconazole
Voriconazole gcaspofungin g
posaconazole
DAMB¥gLAMBgcaspofungin +
itraconazole i.v.
subsequent with voriconazole
p.o.gItraconazole p.o.
DAMB + Itraconazole + IFN-ggIV
voriconazolegvoriconazolep.o£
Amphotericin BgVoriconazole
+ IFN-g
IV voriconazolegPO
voriconazole
VoriconazolegVoriconazole
+ LAMB
DAMB + IFN-g gDAMB
+ IFN-g + 5 - flurocytosine

LAMB -> IV voriconazole ->
Voriconazole + IFN-g + G - CSF

Outcome

Expired
Survived
Survived
Survived

Survived
Survived
Survived
Survived

Expired

Expired

*LAMB: Liposomal Amphotericin B, ¥: DAMB - deoxycholate Amphotericin B, £: p.o - per oral.

scapular region. Other systemic examination was
unremarkable. A clinical diagnosis of left sided lobar
pneumonia (possible bacterial etiology) was made and
he was empirically prescribed oral linezolid and
ibuprofen three times daily and advised follow up after
three days.

Figure-1: Opacification in left upper lobe (arrow) suggestive of consolidation.

segment anteriorly and tenderness at left scapular region
posteriorly. There was no erythema or swelling at the left
Vol. 68, No. 9, September 2018

On follow up, the boy had no improvement in his
symptoms. He was admitted in hospital, laboratory
investigations were advised and the boy was put on
broad spectrum intravenous antibiotics. Investigations
revealed Hb 6.9 gm.%, TLC of 16200/mm3 with 63%
neutrophils and 30% lymphocytes, platelets of
315,000/mm3. His chest X-ray showed left upper lobe
consolidation (Figure-1). CT-chest with contrast showed
consolidation in apical segment of left upper lobe with
erosion of left 3rd rib posteriorly and mild left sided
effusion (Figure-2). The child underwent an urgent VATS
with biopsy. Histopathology of the biopsy revealed
focal granulomatous response with few fungal hyphae
highlighted on Periodic acid-Schiff-diastase (PASD)
stain. The boy was put on intravenous voriconazole
twice daily. After five days of intravenous voriconazole
therapy fever and pain settled. The child was shifted to
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linked pattern was described without description of
genetic locus.12,13

Discussion

Figure-2: CT - chest showing left upper lobe consolidation (star) and erosion of third
rib (arrow).

oral voriconazole and discharged home. Two weeks later
culture and sensitivity of biopsy specimen grew
Aspergillus nidulans sensitive to voriconazole. The
therapy was continued as the boy was doing well on
follow up. He was advised voriconazole for three months
with Trimethoprim-sulphamethoxazole prophylactic
therapy.
Literature Review: A literature review of Aspergillus
osteomyelitis in patients with CGD in last ten years (2008
- 2017) was performed using the Medline / Pub Med and
Google scholar databases. Searches were conducted
using the terms "chronic granulomatous disease"
"osteomyelitis" and "Aspergillus". References of the
retrieved articles were reviewed for other cases.
We found ten other cases of Aspergillus osteomyelitis in
CGD patients. Age ranged from 2.5 year to 21 years. Nine
of the cases were male and seven patients had successful
recovery from the episode of fungal osteomyelitis. The
fungus identified was A. fumigatus in five cases it was, A.
nidulans in three cases, A. flavus in one case and unspecified Aspergillus in one case. Seven patients received
combined antifungal therapy, most common drug was
Voriconazole followed by Amphotericin B and Interferong. In four cases, the osteomyelitis involved ribs and
vertebrae by the contiguous spread from lung
parenchyma. In three cases lower limb was involved
affecting foot in two cases and tibia in one case. There was
one case of isolated skull osteomyelitis in a nine year old
male child.8 Genotype of CGD was available in seven
cases, four cases having mutation at gp91phox,7-10 one
case with p47-phox11 mutation and in two cases only X-

Patients with CGD are unable to kill certain catalase
positive micro-organisms including certain bacteria
and fungi. Among the bacteria most common are
Staphylococcus aureus and Enterobacteriaceae. From
the fungal group Aspergillus species are more
common.17 As the patient did not respond to therapy
within 72 hours, he was admitted and intravenous
Meropenem was started meanwhile markers of fungal
infection b-D-glucan and galactomannan were also
obtained. b-D-glucan level turned to be 91.84 pg/ml
(Normal 60 - 80 pg/ml) and galactomannan level was
0.106 ( positive > 0.7). CT-scan chest was obtained
because of persistent back pain, fever not responding
to broad spectrum antibiotic with mildly raised fungal
markers considering the possibility of fungal infection
and osteomyelitis.
Although Aspergillus fumigatus is the dominant species,
invasive fungal aspergillosis in CGD patients can also be
caused by Aspergillus nidulans and Aspergillus flavus.
Contribution to the infection with each organism was
equal as studied by Dotis and Roilides.18 However, Henriet
S, et al found that A. nidulans caused osteomyelitis in 74%
of infections compared to 41% caused by A. fumigatus
infections.19 It's not exceptional for the primary
pulmonary infection in invasive aspergillosis to extend to
an adjacent rib or vertebrae.17,20
In our patient CT-chest revealed erosion of posterior third
rib. Surgical debridement and biopsy of the lung tissue
was obtained and sent for histopathology and culture
sensitivity. Other common infection that can present
similarly is tuberculosis, involving lung and bone
simultaneously. Xpert MTB/RIF and acid fast bacillus (AFB)
stain with culture sensitivity was also sent to rule out
tuberculous etiology. Tuberculosis work up remained
negative but histopathology showed few fungal hyphae.
So we started intravenous voriconazole 200 mg / dose
twice daily till the final culture report.
Post-operatively our patient made smooth recovery. His
back pain and fever subsided five days after starting
intravenous voriconazole. Similar case was reported in a
5-year-old boy, known case of CGD, where Aspergillus
was the cause of osteomyelitis of the ribs. Treatment with
Amphotericin B and INF-g achieved effective response in
the patient.21 Other pharmacological options to treat
invasive fungal aspergillosis are Amphotericin B,
caspofungin and posaconazole. Attributed to its superior
tolerance and better survival Voriconazole is now
J Pak Med Assoc
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regarded as the drug of choice for invasive aspergillosis as
compared to amphotericin.22
Our patient was discharged home fever and pain free on
oral voriconazole to be followed in outpatient
department (OPD) on weekly basis. Two weeks later the
final report of histopathology and microbiology
confirmed Aspergillus nidulans grown from the biopsy
specimen. Last seen in OPD six weeks after discharge, the
patient is doing well on voriconazole therapy.

Conclusion
The clinicians must be vigilant about the spectrum of
infections in patients with chronic granulomatous
disease. Definitive speciation of invasive fungal infection
in CGD is important. Early and accurate diagnosis can be
reached by appropriate consultation with paediatric
surgeon and microbiologists. Management of CGD has
improved dramatically with antifungal prophylaxis and
better antifungal drugs.
Disclaimer: None to declare.
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